Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
BörsenkürzelGELS
Name des UnternehmensGelteq Ltd
IPO-datumOct 29, 2024
CEOMr. Nathan Jacob Givoni
Anzahl der mitarbeiter7
WertpapierartOrdinary Share
GeschäftsjahresendeOct 29
AddresseLevel 4
StadtMELBOURNE
BörseNASDAQ Capital Market Consolidated
LandAustralia
Postleitzahl3205
Telefon61390873990
Websitehttps://www.gelteq.com
BörsenkürzelGELS
IPO-datumOct 29, 2024
CEOMr. Nathan Jacob Givoni
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten